Aveanna Healthcare Holdings Inc (NASDAQ:AVAH) shares traded -0.83% lower at $4.79 on Wall Street last session.
AVAH stock price is now -5.82% away from the 50-day moving average and -4.67% away from the 200-day moving average. The market capitalization of the company currently stands at $934.50M.
On November 30, 2023, UBS recently initiated its ‘Sell’ rating on the stock quoting a target price of $1.50, while ‘Raymond James’ rates the stock as ‘Mkt Perform’
In other news, Cunningham Patrick A., Chief Compliance Officer sold 18,500 shares of the company’s stock on Jun 13 ’25. The stock was sold for $91,174 at an average price of $4.93. Upon completion of the transaction, the Chief Compliance Officer now directly owns 327,869 shares in the company, valued at $1.57 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 10 ’25, 10% Owner J.H. Whitney Equity Partners V sold 750,000 shares of the business’s stock. A total of $3,900,000 was realized by selling the stock at an average price of $5.20. This leaves the insider owning 28,890,756 shares of the company worth $138.39 million. A total of 73.55% of the company’s stock is owned by insiders.
During the past 12 months, Aveanna Healthcare Holdings Inc has had a low of $2.32 and a high of $6.19.
The company reported revenue of $559.22 million for the quarter, compared to $490.65 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 13.98 percent.
